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2214-031X/Copyright ª 2013, The Aut
license (http://creativecommons.org/Summary The AO Research Institute Davos has the right conditions within the AO Foundation
to promote success in the translation of scientific results into procedures and devices to help
the patient in the following key aspects:
(1) Multidisciplinary highly motivated and focused research team in one location.
(2) Accreditation of research and development processes, facility and animal care.
(3) Good, strong, and well-respected surgeon network for clinical guidance (regional based).
(4) A central clinical trials team with regional knowledge that can host multicenter trials and
can give accreditation to hospitals.
(5) Access to an experienced medical guided approval body with independent surgeons with
regional representation.
(6) Access to a clinical education team based on faculty development and curriculum devel-
opment processes.
This perspective paper attempts to describe some of the multifactorial ingredients to the
success of the translation of diligent research from the AO Research Institute Davos through
the AO Foundation’s value chain of clinical research, surgeon-based approval bodies, and
worldwide postgraduate education system back to the surgeon and ultimately the patient.
Copyright ª 2013, The Author. Published by Elsevier (Singapore) Pte Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).History
The Laboratory for Experimental Surgery in Davos, as the
heart of the AO Foundation, was established as a nonprofitfoundation.org.
07.009
hor. Published by Elsevier (Singap
licenses/by-nc-nd/4.0/).institution by the founding members of the Association for
the Study of Internal Fixation [Arbeitsgemeinschaft fu¨r
Osteosynthesefragen (AO)] in 1959. It was also in Davos that
the first ever AO Course for surgeons was held in 1960. Since
then our highly-respected AO faculty has been training
thousands of medical professionals in state-of-the-art
treatment methods and tools for bone healing and betterore) Pte Ltd. This is an open access article under the CC BY-NC-ND
12 R.G. Richardspatient care around the world. It is not the aim of this short
article to cover the history of the AO; for a good history of
the early years of the AO, the reader is referred to The AO
Phenomenon [1], which shows how AO exponentially has
improved the treatment of fractures through surgery with
dedicated research, development, clinical documentation,
and education of the surgeons, from which AO has since
become a worldwide establishment with a global network
of dedicated surgeons. A recent 4-min film [2] gives an
overview of the work of the AO Foundation. The film de-
scribes how the AO fosters one of the world’s most exten-
sive surgical networks and the role of the global group of
volunteer medical experts, AO Specialties and Institutes in
maintaining its global reputation for excellence in research
and development, clinical investigation, and education.
From 1967 to 1995, Professor Dr med Stephan Perren
pushed AO research towards the area of bone biome-
chanics. The main focus of this fundamental basic and
translational work was placed on the interaction of me-
chanical and biological influences on bone formation,
remodelling, and healing. Major progress was made with
respect to the biology of internal fracture fixation, whereby
new tissue-friendly implants, such as plates with limited
contact or without contact to the underlying bone and
tissue-friendly surgical procedures were developed. Pro-
fessor Perren also created a development group responsible
for the transfer of the research achievements towards
practical applications. Often the ARI went against accepted
scientific and clinical hypotheses that were considered
around the world as fact and ARI was often proved right
through diligent science. This open thinking to question
supposed facts continues within the ARI to this day. The ARI
was innovative in disseminating information, having set up
the first AO web site in 1991 (at that time for internal
purposes), going public in 1992 to get information out on
ARI work and on AO courses to possible participants. From
1997 to 2008 under the directorship of Professor Erich
Schneider, new focus areas were found in the field of
fracture fixation of the osteoporotic skeleton, and in the
enhancement of bone defect regeneration using a com-
bined approach in which conventional load-bearing fixation
devices are supplemented by biodegradable scaffolds.
Since 2008, I have had the honour to direct the Institute
with the themes of restoration and regeneration in the
exploratory areas (e.g., tissue engineering, infection) and
concepts in the developmental area (e.g., aiming devices,
fracture monitoring with sensing, and reacting implants)
[3]. An update of selected projects from the ARI including
an overview to the success can be viewed on the recorded
webinar from December 2012 as part of the AOTRAUMA
surgeon education courses [4].
In 1990 the Board of AO Trustees decided to build an AO-
owned centre and decided that the Research Institute
should not “belong” to any particular university but should
be autonomous, engaging in relationships with numerous
universities. This was a particularly important decision that
has enabled the Institute to continue with research success
and to be a neutral partner in many international societies,
allowing expansion of our networks and collaborations.
Davos was seen as an ideal place for undisturbed thinking
and research. In June 1992, the AO employees moved to the
purpose built AO centre. The Laboratory for ExperimentalSurgery in Davos was renamed the AO Research Institute
Davos (ARI). Work at the AO Centre is performed in an open
and friendly atmosphere, with effectiveness stemming
from friendship and mutual trust. The same philosophy is
used with all our partnerships through projects with other
Foundations, Universities, and Industrial collaborations.Multidisciplinary project based research and
development
In January 2011, 12 leading Massachusetts Institute of Tech-
nology (MIT) researchers in USA noted in a white paper enti-
tled The Third Revolution that convergence of disciplines is
the future ofmedical research to give revolutionary advances
in biomedicine [5]. Convergence involves the merger of life,
physical, and engineering sciencese to foster the innovation
necessary to meet the growing demand for accessible,
affordable healthcare. The ARI has been practicing the basics
of convergence of disciplines of medical research since its
start in 1959, working together from Day 1 as a multidisci-
plinarymotivated research teamon clinical problems through
focused project goals along with developing tools together to
help solve these research problems, such as early six degree
of freedom machines, early stereolithography devices, ul-
trasound microscopes, and bioreactors, all to help solve the
clinical problems. The members of the ARI have always
included specialists in various disciplines of medical surgery,
dentistry, materials science, biomechanics, biomedical en-
gineering, chemistry, biology, and veterinary medicine. This
multidisciplinary team, who all work together on projects,
rather than competing as separate entities, has helped the
revolution that the AO Foundation has brought to achieve
more effective patient care in fracture fixation worldwide.
The whole financial organisation of the Institute is also
project based, stimulating team work towards the clinical
goals of the research projects.
The AO Centre functions as the headquarters for the four
institute pillars of the foundation: ARI, AO Clinical Investi-
gation and Documentation (AOCID), AO Education, and the
AO Technical Commission (AOTK) along with the current
four AO clinical divisions (AOTRAUMA, AOSPINE, AOCMF,
AOVET) and the AO Foundation’s support units. The inter-
disciplinary staff and research of ARI is oriented towards
solving major clinical problems under the medical guidance
of the clinical divisions by improving the knowledge of bone
physiology and related principles and techniques creating
knowledge for AO clinical divisions and AO education to
disseminate. The spreading of the knowledge created
within the ARI helps maintain and increase the academic
credibility for the AO Foundation as a whole including its
clinical divisions. The ARI members also strive for technical
improvements of trauma treatment working closely with
the medical experts of the AOTK, all directed towards
better patient care. The AOTK expert groups (which consist
of expert surgeons in the particular field, from separate
regions of the world, including Asia, America, Europe Latin
America, and the Middle East) define the clinical priorities
on which the ARI works together with them. They also
select clinically relevant projects, project teams, and test
clinics for the ideas giving medical guidance and supervision
of method application or industrial product development.
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for new products that have gone through this rigorous
testing evaluation. In the AOTK, clinical demands always
dominate the process and every idea has to survive intense
specialist discussion, where often technical dreams are
frequently transformed by the clinical needs into realistic
outcomes.
The ARI, and therefore AO, has always been at the
frontline of research into osteosynthesis as well as many
other fields that affect the future of orthopaedic and
trauma surgery. Advances made in the field of osteoporosis,
cell biology, tissue engineering, infection, materialetissue
interfaces, and biomechanics at the ARI illustrate the
extent of the research expertise developed here over the
decades. The AO Centre is also closely linked to the Davos
Congress Centre within Science City Davos, from where the
AO’s developments are usually first taught. Open exchange
between participants and faculty during practical exercises
and group discussions allows knowledge transfer to occur in
a memorable mode for the participants. The knowledge can
be deepened offline through AO books, e-learning, and
audioevisuals on the AO and clinical division web portals
along with articles in AO journals. The AO Education Insti-
tute [6] is involved in the board of the Global Alliance for
Medical Education one of the leading not-for-profit orga-
nisations dedicated to the advancement of innovation in
medical education throughout the world. Through research
and education, the AO Foundation has created an interna-
tional reputation as a leading centre for the improvement
of patient care in trauma and disorders of the musculo-
skeletal system.
The AO value chain (Fig. 1) shows graphically how con-
cepts are created (within the clinical divisions or In-
stitutes), tested in preclinical research, checked for clinicalFigure 1 Collaboration along the AO value chain from the clinic
based approval of the technique, method, implant, or substance, to
clinical problem.suitability for the required clinical problem with expert AO
network surgeons, adjusted and retested prior to possible
clinical trials with AOCID and negotiations with possible
industrial partners or initiation of a spin-off company is
considered in the translation to a possible product. The
final stage is education of the surgeon in the developed
concept, the treatment methodology, or use of developed
substance or implant, prior to improvement of the patient
care.ARI mission and goals
The mission of the ARI is “Excellence in applied preclinical
research and development within trauma and disorders of
the musculoskeletal system and translation of this knowl-
edge to achieve more effective patient care worldwide”.
Within the mission the following goals exist, which the ARI
strives to achieve: contribute high quality applied preclin-
ical research and development (exploratory and trans-
lational) focused towards clinical applications/solutions;
investigate and improve the performance of surgical pro-
cedures, devices and substances; foster a close relationship
with the AO medical community, academic societies, and
universities; and provide research environment/support for
AO clinicians.
Because there is often confusion between scientists and
clinicians on exploratory and translational research, the
following definitions are used. All ARI projects are Applied
Preclinical Research or Applied Preclinical Development
projects focused towards clinical applications. Within the
applied research: Exploratory Applied Preclinical Research
is fundamental research, to solve major clinical problems
over an extended timeframe (over 10 years); andal problem to preclinical research, clinical research, surgeon
education of use at the AO courses and finally back to help the
Figure 2 International ARI medical fellows undergoing biomechanical testing training with cadaveric specimens.
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oping a clinical applicable result in around 5 years and
builds upon the fundamental applied preclinical research.
This research is usually not possible without the previous
fundamental applied preclinical research.Why does the AO research model work?
Fellowships
The ARI’s multidisciplinary team working on project based
clinical problems defined from the AO Foundation’s clinical
division’s members keeps the research focus on track. The
ARI also has a large amount of collective knowledge with
permanent staff (non-PhD students or postdoctoral fellows)
with some celebrating up to 40 years employment at the
Institute. The team also hosts a large number of medical
research fellowships with a 6e12 month stay at ARI, where
the basics of running a scientific project are taught through
active participation within an ongoing project to fellows
from all over the world (Fig. 2). This helps tie into our
network promising future leaders in trauma, inspiring them
to continue to grow within the AO Foundation and to
collaborate, and teach as future faculty for the Foundation.Figure 3 Discussion at the eCM conference onAcademic credibility
The ARI has built strong connections to the Orthopaedic
Research Society (ORS), where we have held workshops and
stand on committees. We have also initiated better contact
with the Orthopaedic Trauma Association (OTA) where we
have been involved in 2010e2012 in organising the symposia
at the basic science focus forum and improving overall AO
Foundation and OTA relations. Moving eastwards we have
been involved within the World Orthopedic Alliance (WOA)
basic science course in 2012 and 2013 and intend to
continue this, along with the AO clinical division symposia
at the annual Chinese Orthopedic Association (COA) meet-
ings. The continual improvement in quality of our publica-
tions within the trauma area (steadily increasing in impact
factor), acquiring major national and international grants
by ARI team members since the 1990s has helped make the
ARI team visible in the academic community. The ARI
team’s presence at high quality international conferences,
within editorial boards and societies in committees, chair-
ing positions, holding keynote lectures as well as organizing
important conferences, such as the yearly electronic Cells
& Materials (eCM) conference (Fig. 3), European Ortho-
paedic Research Society (EORS2010), and European Society
for Biomaterials (ESB2009), have all helped to bring even
more academic credibility to the whole Foundation.the topic of infection around implants, 2011.
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The differences between the ARI and an entity at a university
or a university itself are manifold. Apart from the multidis-
ciplinary team working on project based clinical problems in
one location, the ARI team members have direct access to
expert clinicians worldwide through the AO Foundation, its
clinical divisions, and the AOTK. This brings clinical knowl-
edge on a regional basis with regional and worldwide
knowledge and clinical problems from a several thousand-
strong faculty and even larger network, which is just not
possible through a university or industrial research unit. The
AO network is always happy to support the Foundation with
clinical expertise and advice. The ARI, being a foundation in
its own right, allows the team to have collaborations any-
where in the world with numerous partners, which can be
seen in our annual activity reports, in our grants and publi-
cation lists, along with our collaborators lists.
Innovation in scientific dissemination of data
During the first ARI eCM conference in Davos in June 1999,
prior to when open access was a term in the scientific
publishing world, the idea of an online “free-to-all” scien-
tific journal was initiated. A team of internationally
established scientists was created to conduct the reviews.
An editorial process was set up and all the work was
voluntary. The first volume was launched in January 2001.
The goal was to accept only high level publications putting
them through a rigorous review procedure. There was also
the unique area, Discussion with reviewers section at the
end of each paper, keeping the review procedure more
open and transparent than traditional journals to minimise
possible favouritism or prejudice. The eCM journal was now
live, with a group of dedicated scientists working as vol-
unteers to promote it. In June 2009, the first impact factor
was given: 4.289, straight in at number three in the bio-
materials field. The eCM journal was fed, along with stan-
dard submission, with excellent papers from the annual
single-session focused topic eCM conferences in Davos
(Fig. 3), which started in 1999 and continues today with
subject areas repeating on 4-year cycles to allow major
changes to occur within the respective fields. eCM was also
one of the first scientific journals with a transparent review
processes and governance, including a transparent route to
becoming a member of the Editorial Review Board. The
model has also helped further the academic credibility of
the ARI and AO Foundation worldwide in the science fields
of biomaterials, biomedical engineering, tissue engineer-
ing, and musculoskeletal research. The model has caused
many traditional journals to rethink their models of pub-
lishing, many adapting to this successful model, created by
scientists for the benefit of science.
Internal finances and extramural funding
On financial terms the ARI has created intellectual property
since its start in June 1959 (when the Laboratory for
Experimental Surgery was established in Davos) that has
helped fund the Foundation since that time. Originally,
Intellectual Property (IP) was licenced through twoindustrial partners, Mathys and Straumann, (which formed
Stratec Medical in 1990 for its trauma side) and from 1975
Synthes USA also providing funds to the Foundation. In 1999
the merger of Stratec Medical and Synthes and in 2004
Mathys (osteosynthesis department), AO was then with one
partner, which had possible negative indications with the
external view on the Foundation’s independence. There-
fore the IP including many patents and the Synthes trade-
mark were sold to the Synthes company in 2006 by the
commercial subsidiary of the AO Foundation to provide the
AO Foundation with a financial endowment. The interest
from this endowment is used in many aspects of the
Foundations work from Research performed at the ARI to
the AO Socio Economic Committee whose goal is to improve
the care of the injured in developing countries by con-
ducting or facilitating teaching events and programmes and
supporting the training of individuals involved in these
programmes. The ARI itself brings in about 30% of its annual
funding through extramural sources, holding several FP7
projects.
As an example of the external funding acquired, the ARI is
the scientific coordinator of a unique EuropeaneChinese
joint funded project. Together, renowned European and
Chinese partners have successfully competed in the first
joint EU-FP7 and National Natural Science Foundation of
China (NSFC) research call to date. The consortia will work
on Rapid Prototyping of Custom-Made Bone-Forming Tissue
Engineering Constructs (RAPIDOS; Fig. 4). The European
partners Professor D.W. Grijpma from the University of
Twente, The Netherlands, Professor T. Peijs from Queen
Mary College, London, UK; Professor J. de Bruijn from Xpand
Biotechnology AG based in The Netherlands, and the AO
Research Institute Davos will together receive 1.7 million
Euros of funding. The Chinese partners in this consortia are
Professor L. Qin from Translational Medicine Research and
Development Center of the Shenzhen Institutes of advanced
Technology, Chinese Academy of Sciences; Professor T.-T.
Tang from the Shanghai Key Laboratory of Orthopaedic
Implant at Shanghai Jiao Tong University; and Professor S.B.
Lu and Dr J. Peng from The Institute of Orthopaedics of
Chinese People’s Liberation Army General Hospital in Bei-
jing. The planned scientific exchanges and scientific work-
shops are truly unique opportunities for the ARI to exchange
with these other leading scientists in Europe and China. The
first official meeting will be attached to the COA meeting in
Beijing in November 2013.Certification/accreditation
The entire AO Research Institute Davos is certified according
to ISO 9001:2008. The Institute is one of the very few aca-
demic research organizations that have achieved certifica-
tion. Additionally, the focus fields Biomechanical Research
and Development and Concept Development are certified as
medical device manufacturers according to EN ISO
13485:2012, which demands a much higher level of docu-
mentation and traceability. The ARI’s Preclinical Facility has
AAALAC accreditation. AAALAC International stands for the
Association for Assessment and Accreditation of Laboratory
Animal Care and is a private, nonprofit organisation that
promotes the humane treatment of animals in science
Figure 4 The RAPIDOS project partners meeting in Davos, on the 21st of June 2013. Professor T.-T. Tang, Professor R.G. Richards,
Dr L. Kamer, Dr D. Eglin, Professor J. de Bruijn, Dr Z. Li, Dr H. Yuan, Professor M. Alini, Professor DW. Grijpma, and Professor L. Qin.
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Currently (2013), ARI is one of the three accredited in-
stitutions in Switzerland, and the only accredited academic
Research Institute in Switzerland. The accreditations are
important for the proper function of the institute in its dual
role of academic and device-related research and testing.
AO funded consortia
Through the surgeon network the ARI also collaborates in
worldwide AO consortia, which work collaboratively, on a
peer-to-peer basis, towards the solution of musculoskeletal
clinical problems, where the AO Foundation or AO clinical
Divisions fund both internal and external research within a
consortium. The funds are distributed to the researchFigure 5 Successful ARI spin-off from 2012 (RISystem AG, Davos
www.risystem.com/Standardized_Implant_for_Research/RISystem.partners based on their project contributions. All project
applications are peer reviewed by external reviewers
within the AO Research Review Commission’s review pro-
cess [7]. There are two versions of these consortia, the first
being more exploratory in nature yet still being applied in
preclinical research to a clinical problem, collaborative
research programs (CRP) funded directly by the AO Foun-
dation and the second being more translational clinical
priority programs (CPP), which are funded by the AO
Foundation through its clinical divisions.
Each CRP and CPP is composed of an international,
interdisciplinary network of research teams which work on
collaborative projects towards the consortium goal. To
ensure proper function of the network, the primus inter
pares from the ARI is responsible for the scientific, Switzerland) on implants for small animal research (http://
html).
Translational research in AO 17coordination of the CRPs. The ARI is a mandatory partner in
each AO funded consortium (CRPs and CPPs). CRPs are
typically funded for 6 years and conclude with a preclinical
proof of concept study testing the consortium developed
repair technique/device. The current running CRP consor-
tia are: Annulus Fibrosus Ruptures e this programme is
aimed at developing solutions for the treatment of annulus
fibrosus rupture; and Acute Cartilage Injury e this pro-
gramme is aimed at assessing problems of acute cartilage
injury and at developing solutions for treatment. Both have
major multieconsortium-author review articles recently
published [8,9]. The CPP research is concentrated on clin-
ical and translational research focussing on applications
and methods. The clinical division AOTRAUMA focuses on
two main research areas for their CPPs, bone infection and
fixation in osteoporotic bone. The CPPs not only produce
preclinical research results, but, together with AOCID, run
clinical research studies and develop educational courses.
Examples of this include the masters level Current Concepts
course on infection run at the AO courses in Davos in 2012,
which will be run again in 2013, and the Geriatric course
originally run in Davos and now taught in many AO courses
worldwide.Spin-offs and handovers within the value chain
In 2012 the AO created a spin-off company RISystem AG
(Fig. 5). The RISystem are standardised, defined, and
reproducible microimplant kits/systems with reproducible
biomechanics for research in bone biology with small ani-
mals (mice, rats, rabbits) from internal fixation systemsFigure 6 Current ARI CONCEPT DEvelopment treatment chain. C
the required clinical problem with expert AO network surgeons,
dustrial partners or initiation of a spin-off company is considered i(stable and non-stable), locking nails, external fixators to
distraction systems. This is the first spin-off of the ARI since
Synbone in 1992. Synbone produces anatomical models for
teaching orthopaedic and surgical procedures and is used
worldwide at AO Foundation courses and other society
courses. The other very successful focus area from ARI Skill
training technology with two core projects: the PlayGround
for trauma surgeons; and the Oskit (a reusable fracture
fixation learning box based on the Mu¨ller Classification)
were handed over in the value chain to AO Education Skill
Training Technology is a technical parcours (training
ground) for orthopaedic trauma surgeons with a focus on
surgical skills. It is an innovative, clever way to enhance the
knowledge about underlying principles through practical
hands-on exercises that allow surgeons to get a feeling for
what a technique feels like. It enhances the educational
offerings of the Foundation in a unique and practical
manner. It supports the continuous education of a surgeon
and is being used at many AO courses with great success.
The ARI will continue to look at spin-offs as one of the
modes of technology transfer along with selling concepts
and intellectual property to industry as another mode of
technology transfer (Fig. 6).
The AO Foundation
The AO Foundation is a medically guided not-for-profit
organisation led by an international group of surgeons
specialized in the treatment of trauma and disorders of the
musculoskeletal system. The AO network was founded in
1958 by 13 visionary Swiss surgeons. AO today fosters one ofoncepts are created, tested, checked for clinical suitability for
adjusted, and retested prior to negotiations with possible in-
n the translation to a possible product.
18 R.G. Richardsthe most extensive networks of currently more than 12,000
surgeons, operating room personnel, and scientists in over
100 countries worldwide.Acknowledgements
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